Clonal circulating cells are common in plasma cell proliferative disorders: A comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma

Blood

Volumn 88, Issue 1, 1996, Pages 289-296

  Billadeau, Daniel ^b   Van Ness, Brian ^b   Kimlinger, Terry ^b   Kyle, Robert A ^b   Therneau, Terry M ^b   Greipp, Philip R ^b   Witzig, Thomas E ^a  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; CD45 ANTIGEN;

AMYLOIDOSIS; ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MONONUCLEAR CELL; MULTIPLE MYELOMA; MYELOMA; PLASMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0029957126     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.1.289.bloodjournal881289     Document Type: Article

References (41)

1. Axelsson U, Bachmann R, Hällen J: Frequency of pathological proteins (M-components) in 6,995 sera from an adult population. Acta Med Scand 179:235, 1966
2. Kyle R, Finkelstein S, Elveback L, Kurland L: Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood 40:719, 1972
3. Blade J, Lopez-Guillermo A, Rozman C, Cervantes F, Salgado C, Aguilar J-L, Vives-Corrons J-L, Montserrat E: Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haematol 81:391, 1992
4. Kyle R: "Benign" monoclonal gammopathy after 20-35 years of follow-up. Mayo Clin Proc 68:26, 1993
5. Witzig T, Dhodapkar M, Kyle R, Greipp P: Quantitation of circulating peripheral blood plasma cells and their relationship to disease activity in patients with multiple myeloma. Cancer 72:108, 1993
6. Berenson J, Wong R, Kim K, Brown N, Lichtenstein A: Evidence for peripheral blood B lymphocyte but not T lymphocyte involvement in multiple myeloma. Blood 70:1550, 1987
7. Billadeau D, Quam L, Thomas W, Kay N, Greipp P, Kyle R, Oken MM, Van Ness B: Detection and quantitation of malignant cells in the peripheral blood of multiple myeloma patients. Blood 80:1818, 1992
8. Boccadoro M, Omedé P, Massaia M, Dianzani U, Pioppo P, Battaglio S, Meregalli M, Pileri A: Human myeloma: Several subsers of circulating lymphocytes express plasma cell-associated antigens. Eur J Haematol 40:299, 1988
9. Caligaris-Cappio F, Bergui L, Gaidano G, Schena M, Putto P, Merico F, Riva M: Circulating malignant precursors in monoclonal gammopathies. Eur J Haematol Suppl 43:27, 1989
10. Pilarski L, Belch A: Circulating monoclonal B cells expressing P clycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood 83:724, 1994
11. Sawamura M, Murakami H, Tamura J, Matsushima T, Sato S, Naruse T, Tsuchiya J: Tumor necrosis factor-α and interleukin 4 promote the differentiation of myeloma cell precursors in multiple myeloma. Br J Haematol 88:17, 1994
12. Omedé P, Boccadoro M. Gallone G, Frieri R, Battaglio S, Redoglia V, Pileri A: Multiple myeloma: Increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival. Blood 76:1375, 1990
13. Shimizu K, Murate T, Kunii A: Circulating immunoglobulin-secreting cells in patients with plasma cell dyscrasia. Blood 55:590, 1980
14. Bagg A, Becker P, Bezwoda W, Van Rensburg L, Mendelow B: Circulating monotypic B-cells in multiple myeloma: Association with lambda paraproteins. Br J Haematol 72:167, 1989
15. Chiu E, Ganeshaguru K, Hoffbrand A, Mehta A: Circulating monoclonal B lymphocytes in multiple myeloma. Br J Haematol 72:28, 1989
16. Cassel A, Leibovitz N, Hornstein L, Quitt M, Aghai E: Evidence for the existence of circulating monoclonal B-lymphocytes in multiple myeloma patients. Exp Hematol 18:1171, 1990
17. Fend F. Weyrer K, Drach J. Schwaiger A, Umlauft F, Grünewald K: Immunoglobulin gene rearrangement in plasma cell dyscrasias: Detection of small clonal cell populations in peripheral blood and bone marrow. Leuk Lymphoma 10:223, 1993
18. Yamada M, Hudson S, Tournay O, Bittenbenders S, Shane SS, Lange B, Tsujimoto Y, Caton AJ, Rovera G: Detection of minimal residual disease in hematopoietic malignancies in B-cell lineage by using third-complementary-determining region (CDRIII)-specific probes. Proc Natl Acad Sci USA 86:5123, 1989
19. Yamada M, Wasserman R, Lange B, Richard BA, Womer RB, Rovera G: Minimal residual disease in childhood B-lineage lymphoblastic leukemia. N Engl J Med 323:448, 1990
20. Jonsson OG, Kitchens RL, Scott FC, Smith RG: Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes. Blood 76:2072, 1990
21. Billadeau D, Blackstadt M, Greipp P, Kyle RA, Oken MM, Kay N, Van Ness B: Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: A technique for sequential quantitation of residual disease. Blood 78:3021, 1991
22. Vescio RA, Hong CH, Cao J, Kim A, Schiller GJ, Lichtenstein AK, Berenson RJ, Berenson JR: The hematopoietic stem cell antigen, CD34 is not expressed on the malignant cells in multiple myeloma. Blood 84:3283, 1994
23. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 86:390, 1995
24. + stem cells do not contain clonal myeloma cells. Blood 86:381, 1995
25. Kyle R: Monoclonal gammopathy of undetermined significance. Blood Rev 8:135, 1994
26. Greipp P, Witzig T, Gonchoroff N: Immunofluorescence labeling indices in multiple myeloma and related monoclonal gammopathies. Mayo Clin Proc 62:969, 1989
27. Witzig T, Kyle R, O'Fallon W, Greipp P: Detection of peripheral blood plasma cells as a predictor of disease course in patients with smoldering multiple myeloma. Br J Haematol 87:266, 1994
28. Witzig T, Gonchoroff N, Ahmann G, Katzmann J, Greipp P: T-cell depletion using anti-CD2 coated magnetic beads simplifies the detection of peripheral blood plasma cells. J Immunol Methods 144:253, 1991
29. Westendorf J, Ahmann G, Armitage R, Spriggs M, Lust J, Greipp P, Katzmann J, Jelinek D: CD40 expression in malignant plasma cells: Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J Immunol 152:117, 1994
30. Witzig T, Kimlinger T, Ahmann G, Katzmann J, Greipp P: Detection of myeloma cells in the peripheral blood by flow cytometry. Cytometry 1996 (in press)
31. Billadeau D, Ahmann G, Greipp P, Van Ness B: The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. J Exp Med 178:1023, 1993
32. Aubin J, Davi F, Nguyen SF, Leboeuf D, Debert C, Taher M, Valensi F, Canioni D, Brousse N, Varet B, Flandrin G, Macintyre EA: Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia 9:471, 1995
33. Zandecki M, Facon T, Preudhomme C, Canis F, Izydorczyk V, Lovi V, Hammad M, Bauters F, Cosson A: Significance of circulating plasma cells in multiple myeloma. Leuk Lymphoma 14:491, 1994
34. Goto H, Shimazaki C, Ashihara E, Ohkawa K, Oku N, Inaba T, Murakami S, Fujita N, Nakagawa M: Effects of interleukin-3 and interleukin-6 on peripheral blood cells from multiple myeloma patients and their clinical significance. Acta Haematol 88:129, 1992
35. Büchi G, Giorotto M, Veglio M, Clerico M, Gario S, Termine G, Autino R: Kappa/lambda ratio on peripheral blood lymphocytes and bone marrow plasma cell labeling index in monoclonal gammopathies. Haematologica 75:132, 1990
36. Pettersson D, Mellstedt H, Holm G, Bjøorkholm M: Monoclonal blood lymphocytes in benign monoclonal gammopathy and multiple myeloma in relation to clinical stage. Scand J Haematol 27:287, 1981
37. Isaksson E, Björkholm M, Holm G, Johansson B, Mellstedt H, Österborg A: Blood clonal B-cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): Association with malignant transformation. Br J Haematol 92:71, 1996
38. Österborg A, Steinitz M, Lewin N, Bergenbrant S, Holm G, Lefvert A-K, Mellstedt H: Establishment of idiotype bearing B-lymphocyte clones from a patient with monoclonal gammopathy. Blood 78:2642, 1991
39. Witzig T, Gonchoroff N, Katzmann J, Therneau T, Kyle R, Greipp P: Peripheral blood B-cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies. J Clin Oncol 6:1041, 1988
40. Greipp P, Kyle R: Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma. Blood 62:166, 1983
41. Sahota S, Leo R, Hamblin T, Stevenson F: Immunoglobulin V (H) gene mutational patterns indicate different tumor cell status in human myeloma and MGUS. Blood 87:746, 1996